Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Device to facilitate moving an electrical cable of an electric vehicle charging station and method of providing the same
Method for producing a flexible composite elastomeric polyurethane skin
Topology arrangement for achieving reliable communication in wireless automotive networks
Linear jet ionizer
Blue box
Wafer recycling method
High electron mobility transistor and manufacturing method thereof
  Randomly Featured Patents
Wood bending methods employing fast curing phenolic resins
Grape plant named `Arrafifteen`
Method of making chip scale package
Lamp with mercury release structure and method for dispensing mercury into a lamp
Method for discriminating the kind or type of printed circuit board to selectively set the mounting process therefore
Rotary food cooking device for a grill
Acceleration sensor for detecting inertia forces
Method and apparatus for wafer-level testing of semiconductor laser
Ignition interrupt system with stall interval
High-tension high-compression foundation for tower structures